National Institute of Cholera and Enteric Diseases, India
11
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
Role: collaborator
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Role: collaborator
Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
Role: collaborator
Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
Role: collaborator
Study of Alternative Vaccination Schedule of Oral Cholera Vaccine
Role: collaborator
Evaluation of a Boosting Regimen With Oral Cholera Vaccine
Role: collaborator
Pilot Introduction of Oral Cholera Vaccine in Orissa, India
Role: collaborator
Mass Oral Cholera Vaccination in Zanzibar
Role: collaborator
Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
Role: collaborator
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Role: collaborator
Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
Role: collaborator
All 11 trials loaded